Arrowhead Pharmaceuticals (ARWR) P/B ratio

P/B ratio today
120.7×

Arrowhead Pharmaceuticals (ARWR) trades at 120.7× its book value per share at the end of fiscal 2026. At the end of fiscal 2026 (September 30, 2026) its P/B ratio was 183.8×. That is 1756.8% higher than the 9.9× of fiscal 2025. Figures as of 18 Nov 2026, 07:18 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/B ratio today
120.7×
P/B ratio, fiscal 2026
183.8×
Change on fiscal 2025
+1756.8%
Highest on record
183.8×fiscal 2026
Lowest on record
2.4×fiscal 2011
Fiscal years on record
132010–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Arrowhead Pharmaceuticals P/B ratio, in more detail

Today's figure is 34.3% below the fiscal 2026 year-end.

Across the 13 fiscal year-ends on record (2010–2026), the highest was 183.8× in fiscal 2026 and the lowest 2.4× in fiscal 2011. Today's P/B ratio is higher than at 92% of the 13 fiscal year-ends on record; their median is 9.9×.

History · 13 fiscal years

P/B ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Arrowhead Pharmaceuticals P/B ratio, year by year

Arrowhead Pharmaceuticals (ARWR) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
Today120.7×—$42.99—
2026183.8× 1,756.8% up$65.45$0.36
20259.9× 20.9% down$34.49$3.48
202412.5× 17.7% up$19.37$1.55
202310.6× 21.5% up$26.87$2.53
20228.7× 44.8% down$33.05$3.78
202115.8× 68.7% up$62.43$3.94
20209.4× 17.3% down$43.06$4.58
201911.4× 32.1% down$28.18$2.48
201816.7× 325.9% up$19.17$1.15
20173.9×—$4.33$1.10
2016——$7.35—
2015——$5.76—
2014——$14.77—
2013——$5.69—
20122.9× 22.0% up$2.62$0.90
20112.4× 68.0% down$3.90$1.63
20107.5×—$10.50$1.41
2009——$6.65—
2008——$10.40—
2007——$50.50—
2006——$49.90—
2005——$29.90—
2004——$55.00—
2003——$5.85—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

P/B ratio at health care companies of similar size

P/B ratio of Arrowhead Pharmaceuticals and comparable companies
CompanyP/B ratio
Axsome Therapeutics AXSM81.0×
Chemed CHE7.2×
Oruka Therapeutics ORKA13.8×
Arrowhead Pharmaceuticals ARWR120.8×
MSA Safety MSA4.9×
CG Oncology CGON9.4×

Today's market value divided by shareholders' equity at the latest fiscal year-end. A company whose statements are in another currency than its shares is left out.

More on ARWR

Arrowhead Pharmaceuticals, figure by figure

Arrowhead Pharmaceuticals (ARWR) overview: price, valuation and scorecardAll health care companies by market value

Arrowhead Pharmaceuticals P/B ratio: questions and answers

What is Arrowhead Pharmaceuticals's P/B ratio?

Arrowhead Pharmaceuticals (ARWR) trades at 120.7× its book value per share at the end of fiscal 2026. At the end of fiscal 2026 (September 30, 2026) its P/B ratio was 183.8×. That is 1756.8% higher than the 9.9× of fiscal 2025.

Is Arrowhead Pharmaceuticals's P/B ratio high or low compared with its own history?

Today's P/B ratio is higher than at 92% of the 13 fiscal year-ends on record; their median is 9.9×.

What are the highest and lowest P/B ratio figures on record for Arrowhead Pharmaceuticals?

Across the 13 fiscal year-ends on record (2010–2026), the highest was 183.8× in fiscal 2026 and the lowest 2.4× in fiscal 2011.

How is Arrowhead Pharmaceuticals's P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Arrowhead Pharmaceuticals (ARWR) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/ARWR/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.